Compared to healthy controls, MDD patients exhibit a reduced proportion of the CD56+CD16− NK cell subset (the primary producer of IFN-γ) and lower serum IFN-γ levels (32–34), suggesting a potential association between NK cell dysfunction and inflammation-related depression development. This evidence concerns the gene NCAM1 and depressive symptom measurement.